Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Chemotherapy often causes skin, hair, and nail problems in cancer patients.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

Some new drugs show potential for treating blood cancers but have serious side effects and need more research.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Many patients on new leukemia drugs had mild to moderate skin reactions.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Docetaxel is effective against various cancers but mainly causes neutropenia.

The treatment is safe and effective for elderly patients with advanced non-small-cell lung cancer.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Females had more chemotherapy side effects than males, with many being preventable.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Nanoparticle systems make cancer treatment less toxic.

Anthocyanins from fruits and vegetables may help prevent and treat colorectal cancer safely.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.